GWPCARE6 TRIAL
Phase 3 clinical study of the effect of Cannabidiol on epilepsy in patients with TSC
In this study with GW Research Ltd, the effect of the drug Cannabidiol on epilepsy was tested. 224 participants took part, including a number of TSC patients from the ENCORE expertise center. The study was completed in 2019 and results are expected shortly.